Oxidative stress and antioxidant status in primary bone and soft tissue sarcoma

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Nathan, Fatima M ^a   Singh, Vivek A ^b   Dhanoa, Amreeta ^a   Palanisamy, Uma D ^a  

^a MONASH UNIVERSITY MALAYSIA   (Malaysia)

^b UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CARBONYL DERIVATIVE; CATALASE; SUPEROXIDE DISMUTASE; THIOL; TROLOX C; 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID; CHROMAN DERIVATIVE; MALONALDEHYDE; THIOL DERIVATIVE;

ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIMARY BONE SARCOMA; PROTEIN BLOOD LEVEL; PROTEIN CARBONYLATION; SCHOOL CHILD; SOFT TISSUE SARCOMA; TROLOX EQUIVALENT ANTIOXIDANT CAPACITY; URINE LEVEL; ADOLESCENT; BLOOD; BONE TUMOR; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; OSTEOSARCOMA; PHYSIOLOGY; SARCOMA; URINE;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; BONE NEOPLASMS; CASE-CONTROL STUDIES; CATALASE; CHILD; CHROMANS; HUMANS; MALONDIALDEHYDE; MIDDLE AGED; OSTEOSARCOMA; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SARCOMA; STATISTICS, NONPARAMETRIC; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE;

EID: 80052036887     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-382     Document Type: Article

References (29)

1. Fletcher CDM, Uni KK, Mertens F, . eds World Health Organisation classification of tumours. Pathology and genetics 2002, Lyon: IARC Press, eds.
2. Dorfman HD, Czerniak B. Bone cancers. Cancer 1995, 75:203-10. 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V, 8000997.
3. Dean BJF, Whitwell D. (i) Epidemiology of bone and soft-tissue sarcomas. Ortho Trauma 2009, 23:223-30.
4. Battisti V, Maders LDK, Bagatini MD, Santos KF, Spanevello RM, Maldonado PA, Brulé AO, Araújo M, Schetinger MRC, Morsch VM. Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukaemia patients. J Clin Biochem 2008, 41:511-18.
5. Wauquier F, Leotoing L, Coxam V, Guicheux J, Wittrant Y. Oxidative stress in bone remodelling and disease. Trends Mol Med 2009, 15:468-77. 10.1016/j.molmed.2009.08.004, 19811952.
6. Chang D, Wang F, Zhao Y, Pan H. Evaluation of oxidative stress in colorectal cancer patients. J Biomed Env Scien 2008, 21:286-89.
7. Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Soc Toxicol Path 2010, 38:96-109.
8. Mazor D, Abucoider A, Meyerstein N, Kapelushnik J. Antioxidant status in pediatric acute lymphocytic leukemia (ALL) and solid tumors: The impact of oxidative stress. J Pediatr Blood Cancer 2008, 51:613-15.
9. Perez-Matute P, Zulet MA, Martinez JA. Reactive species and diabetes:counteracting oxidative stress to improve health. Curr Opin Pharmacol 2009, 9:771-79. 10.1016/j.coph.2009.08.005, 19766058.
10. Goodyear-Bruch C, Pierce JD. Oxidative stress in critically ill patients. Am J Crit Care 2002, 11:543-51.
11. Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol 1998, 108:101-06.
12. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 1996, 25:57-74. 10.3109/10715769609145656, 8814444.
13. Levine RL, Williams JA, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994, 233:357-63.
14. Johansson LH, Borg LAH. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 1988, 174:331-36. 10.1016/0003-2697(88)90554-4, 3064653.
15. Malstrom B, Andreasson L, Reinhammer B. The enzymes. 1975, XIIB Academic Press, New York, Boyer P.
16. Hu M. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994, 233:380-82.
17. Miller N, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993, 84:407-12.
18. Niedernhofer LJ, Daniels JS, Rouzer CA. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem 2003, 278:31426-433. 10.1074/jbc.M212549200, 12775726.
19. Drury JA, Nycyk JA, Cooke RWI. Comparison of urinary and plasma malondialdehyde in preterm infants. Clin Chem Act 1997, 263:177-85.
20. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997, 272:20313-316. 10.1074/jbc.272.33.20313, 9252331.
21. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Tren Mol Med 2003, 9:169-75.
22. Badjatia N, Satyam A, Singh P, Seth A, Sharma A. Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. J Urol Oncol 2009, 28:1-8.
23. Mates JM, Perez-Gomes C, De Castro IN. Antioxidant enzymes and human diseases. Clin Biochem 1999, 32:595-603. 10.1016/S0009-9120(99)00075-2, 10638941.
24. Senthil K, Aranganathan S, Nalini N. Evidence of oxidative stress in the circulation of ovarian cancer patients. Clin Chem Act 2003, 339:27-32.
25. Prakash M, Shetty MS, Tilak P, Anwar N. Total thiols: Biomedical importance and their alteration in various disorders. J Health All Sci 2009, 8:1-6.
26. Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophy 1985, 240:500-08.
27. Brigelius-Flohe R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A. The European perspective on vitamin E:current knowledge and future research. Am J Clin Nutri 2002, 76:703-16.
28. Moller P, Wallin H, Knudsen LE. Oxidative stress associated with exercise, psychological stress and life-style factors. Chemico-Biol Interac 1996, 102:17-36.
29. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Canc Lett 2009, 282:125-36.